Holger Paulsen

This inventor holds 14 USPTO granted patents and 8 published patent applications and 4 EPO patents. Top assignees: Bayer Aktiengesellschaft, Bayer Intellectual Property Gmbh, Aicuris Gmbh + Co. Kg.. Active years: 2000-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Holger Paulsen. Retrieved from https://idiyas.com/inventor/holger-paulsen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14 (Patent Applications = 8)

% Patents Active = 28.6

EPO Patents = 4 (Patent Applications = 7)

Average Co-Inventor Count = 9.2

ph-index = 5

Forward Citations = 115(Granted Patents)

Location History:

Wuppertal, DE (2000 - 2008)
Hilden, DE (2009 - 2015)

Company Filing History:

7 out of 12,266

Bayer Aktiengesellschaft

patents

3 out of 721

Bayer Intellectual Property Gmbh

patents

1 out of 53

Aicuris Gmbh + Co. Kg.

Bayer Healthcare Aktiengesellschaft

patents

6. 1 out of 192

Bayer Schering Pharma Ag

patents

Years Active: 2000-2015

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9023849 - Substituted fused imidazoles and pyrazoles and use thereof (2015-05-05),

2. 8802860 - Method for producing substituted pyridin-2-one (2014-08-12),

3. 8383822 - Substituted oxazolidinones and their use (2013-02-26),

4. 8063234 - Substituted 7-sulfanylmethyl-, 7-sulfinylmethyl- and 7-sulfonylmethylindoles and the use thereof (2011-11-22),

5. 7531507 - Acylated nonadepsipeptides containing pyridyl alanine residues (2009-05-12),

6. 7405201 - Antibacterial macrocycles (2008-07-29),

7. 7074780 - Substituted phenylcyclohexanecarboxamides and their use (2006-07-11),

8. 6984642 - Substituted phenylcyclohexane carboxylic acid amides and their use as adenosine uptake inhibitors (2006-01-10),

9. 6716849 - Substituted phenylcyclohexane carboxylic acid amides that have an adenosine uptake inhibiting effect (2004-04-06),

10. 6649616 - Substituted phenylcyclohexanecarboxamides and their use (2003-11-18),

11. 6586613 - Substituted tetrahydronaphthaline and analogous compounds (2003-07-01),

12. 6344476 - Inhibition of p38 kinase activity by aryl ureas (2002-02-05),

13. 6207671 - Cycloalkano-pyridines (2001-03-27),

14. 6069148 - Cycloalkano-pyridines (2000-05-30),

Title: Holger Paulsen: Innovator in Pharmaceutical Chemistry

Introduction

Holger Paulsen is a distinguished inventor based in Hilden, Germany, known for his significant contributions to pharmaceutical chemistry. With a total of 14 patents to his name, he has made remarkable advancements in the field, particularly in the development of novel compounds for medical applications.

Latest Patents

Among his latest patents, Paulsen has developed substituted fused imidazoles and pyrazoles, which are crucial for the treatment and prophylaxis of various diseases, especially cardiovascular disorders. His work includes a method for producing substituted pyridin-2-one, which serves as an important intermediate compound in drug production. These innovations highlight his commitment to improving healthcare through scientific research.

Career Highlights

Throughout his career, Holger Paulsen has worked with prominent companies such as Bayer Aktiengesellschaft and Bayer Intellectual Property GmbH. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Paulsen has collaborated with notable colleagues, including Joachim Schuhmacher and Carsten Schmeck. These partnerships have further enhanced his research capabilities and have led to significant advancements in his field.

Conclusion

Holger Paulsen's innovative work in pharmaceutical chemistry has made a lasting impact on the industry. His patents and collaborations reflect his dedication to advancing medical science and improving patient outcomes.

Profile summary based on public USPTO records.